1008112-03-5 Usage
Uses
Used in Organic Chemistry:
7-Bromo-2,4-dichloropyrrolo[2,1-f][1,2,4]triazine is used as a building block for the synthesis of various heterocyclic compounds. Its unique structure allows for the creation of a wide range of chemical entities with potential applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical field, 7-Bromo-2,4-dichloropyrrolo[2,1-f][1,2,4]triazine is utilized for its potential applications in the development of new drugs. Its unique chemical properties make it a promising candidate for the synthesis of novel therapeutic agents.
Used in Agrochemical Industry:
7-Bromo-2,4-dichloropyrrolo[2,1-f][1,2,4]triazine is also studied for its potential use in agrochemicals. Its unique structure and properties may contribute to the development of new pesticides or other agrochemical products.
Used in Bioimaging Applications:
7-Bromo-2,4-dichloropyrrolo[2,1-f][1,2,4]triazine has been investigated for its potential use as a fluorescent probe in bioimaging applications. Its unique fluorescent properties make it a valuable tool for visualizing biological processes and structures at the molecular level.
Check Digit Verification of cas no
The CAS Registry Mumber 1008112-03-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,8,1,1 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1008112-03:
(9*1)+(8*0)+(7*0)+(6*8)+(5*1)+(4*1)+(3*2)+(2*0)+(1*3)=75
75 % 10 = 5
So 1008112-03-5 is a valid CAS Registry Number.
1008112-03-5Relevant articles and documents
CD73 INHIBITORS
-
Paragraph 0247, (2021/02/12)
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
PYRROLOTRIAZINE KINASE INHIBITORS
-
Page/Page column 40, (2008/06/13)
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.